Dr. Ghazi discusses different treatment options and related studies with its relevance in clinical practice
Dr. Ghazi Alotaibi, KSA
Edit Video Component
Dr. Ghazi Alotaibi, Consultant Haematologist, King Saud Medical city and Assistant Professor of Medicine at King Saud University, Riyadh, Saudi Arabia, talks about translating data into practice.
• Discussion about case report with the clinical history and treatment approach with maintenance therapy.
• About the DFCI and WUSTL trails.
• Ongoing ECHO phase III trial.
• Summary of different studies of Ibrutinib, acalabrutinib, Ibrutinib-Rituximab,
Dual BTK-BCL2blockade, Zanubrutinib, Venetoclax, Lenalidomide- Rituximab,
Brexucabtagene autoleucel from studies conducted by other researchers
Explore more videos
Configure Image Component
Acalabrutinib and Other Novel Therapies in Mantle Cell Lymphoma
Dr. Michael Wang, US
Configure Image Component
MCL Management in Clinic
Dr. Salem Alshemmari, Kuwait
Configure Image Component
Critical Evaluation of BTKis in CLL
Dr. George Follows, UK
Modal Window Component Section Begins
Modal Window Component Section Ends